Pepdox
Studies
Peptides
Calculator
Semaglutide: a gendered phenomenon-women's increased vulnerability to adverse drug reactions in the global weight loss trend. | Pepdox
Home
/
Search
/
PMID 40290513
Semaglutide: a gendered phenomenon-women's increased vulnerability to adverse drug reactions in the global weight loss trend.
Therapeutic advances in drug safety
2025
PMID: 40290513
View on PubMed
DOI: 10.1177/20420986251332737
Semaglutide
Authors
Castellana, Eleonora; Chiappetta, Maria Rachele
Keywords
Semaglutide
adverse drug reactions
women